Perrigo Ordinary Shares reported $3.51B in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Abbott ABT:US $ 17086M 210M
Abbvie ABBV:US $ 63522M 667M
Bayer BAYN:GR € 36648M 167M
Bristol Myers Squibb BMY:US $ 37450M 2155M
Catalent CTLT:US $ 4157M 34M
Coherus Biosciences CHRS:US $ 420.46M 11.68M
Corcept Therapeutics CORT:US $ 0M 0M
Eli Lilly And LLY:US $ 15152.9M 193.5M
Endo International Ordinary Shares ENDP:US $ 8057.5M 9.85M
Horizon Pharma HZNP:US $ 2552.74M 2.49M
JAZZ PHA JAZZ:US $ 5992.87M 32.34M
Johnson & Johnson JNJ:US $ 28851M 1134M
Lannett LCI:US $ 610.08M 6.6M
Merk MRK:US $ 30586M 104M
Pacira Pharmaceuticals PCRX:US $ 729.74M 55.21M
Perrigo Ordinary Shares PRGO:US $ 3510.6M 593.9M
Pfizer PFE:US $ 35656M 539M
Phibro Animal Health PAHC:US $ 400.62M 13.3M
Prestige Brands PBH:US $ 1481.16M 53.96M
Supernus Pharmaceuticals SUPN:US $ 400.38M 21.13M
Teva Pharmaceutical TEVA:IT 20.84B 777M
Xeris Pharmaceuticals Inc XERS:US $ 137.64M 49.57M
Zoetis ZTS:US $ 5228M 1364M